These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23731989)

  • 1. [Magnetic resonance imaging in management of prostate cancer].
    Boesen L; Thomsen HS
    Ugeskr Laeger; 2013 Jun; 175(23):1630-3. PubMed ID: 23731989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging.
    Delongchamps NB; Rouanne M; Flam T; Beuvon F; Liberatore M; Zerbib M; Cornud F
    BJU Int; 2011 May; 107(9):1411-8. PubMed ID: 21044250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Multiparametric magnetic resonance imaging of the prostate - technique and clinical applications].
    Franiel T
    Rofo; 2011 Jul; 183(7):607-17. PubMed ID: 21487980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparametric magnetic resonance imaging of the prostate: technical aspects and role in clinical management.
    Costa DN; Pedrosa I; Roehrborn C; Rofsky NM
    Top Magn Reson Imaging; 2014 Aug; 23(4):243-57. PubMed ID: 25099562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multiparametric MRI of the prostate: method for early detection of prostate cancer?].
    Schlemmer HP
    Rofo; 2010 Dec; 182(12):1067-75. PubMed ID: 20972932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expanding role of MRI in prostate cancer.
    Murphy G; Haider M; Ghai S; Sreeharsha B
    AJR Am J Roentgenol; 2013 Dec; 201(6):1229-38. PubMed ID: 24261361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiparametric magnetic resonance imaging of the prostate: current status in prostate cancer detection, localization, and staging.
    Macura KJ
    Semin Roentgenol; 2008 Oct; 43(4):303-13. PubMed ID: 18774034
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of high-field MR in studies of localized prostate cancer.
    Lagemaat MW; Scheenen TW
    NMR Biomed; 2014 Jan; 27(1):67-79. PubMed ID: 23703839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local staging of prostate cancer with MRI.
    Soylu FN; Eggener S; Oto A
    Diagn Interv Radiol; 2012; 18(4):365-73. PubMed ID: 22399364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR imaging of the prostate.
    Yacoub JH; Oto A; Miller FH
    Radiol Clin North Am; 2014 Jul; 52(4):811-37. PubMed ID: 24889173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer: multiparametric MR imaging for detection, localization, and staging.
    Hoeks CM; Barentsz JO; Hambrock T; Yakar D; Somford DM; Heijmink SW; Scheenen TW; Vos PC; Huisman H; van Oort IM; Witjes JA; Heerschap A; Fütterer JJ
    Radiology; 2011 Oct; 261(1):46-66. PubMed ID: 21931141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR imaging and MR spectroscopy in prostate cancer management.
    Katz S; Rosen M
    Radiol Clin North Am; 2006 Sep; 44(5):723-34, viii. PubMed ID: 17030223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dynamic contrast-enhanced MRI of the prostate: comparison of two different post-processing algorithms].
    Beyersdorff D; Lüdemann L; Dietz E; Galler D; Marchot P; Franiel T
    Rofo; 2011 May; 183(5):456-61. PubMed ID: 21442558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology.
    Selnæs KM; Heerschap A; Jensen LR; Tessem MB; Schweder GJ; Goa PE; Viset T; Angelsen A; Gribbestad IS
    Invest Radiol; 2012 Nov; 47(11):624-33. PubMed ID: 23011187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
    Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
    J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion-weighted MRI and its role in prostate cancer.
    Tamada T; Sone T; Jo Y; Yamamoto A; Ito K
    NMR Biomed; 2014 Jan; 27(1):25-38. PubMed ID: 23712781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The state of prostate MRI in 2013.
    Gupta RT; Kauffman CR; Polascik TJ; Taneja SS; Rosenkrantz AB
    Oncology (Williston Park); 2013 Apr; 27(4):262-70. PubMed ID: 23781689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic contrast-enhanced magnetic resonance imaging in prostate cancer.
    Kayhan A; Fan X; Oto A
    Top Magn Reson Imaging; 2009 Apr; 20(2):105-12. PubMed ID: 20010065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging.
    Tanimoto A; Nakashima J; Kohno H; Shinmoto H; Kuribayashi S
    J Magn Reson Imaging; 2007 Jan; 25(1):146-52. PubMed ID: 17139633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Imaging of prostate cancer by diagnostic radiology and nuclear medicine].
    Weidner A; Michaely HJ; Pelzer A; Michel MS; Wenz F; Schoenberg SO; Dinter DJ
    Aktuelle Urol; 2010 Jan; 41(1):35-42. PubMed ID: 20101785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.